Paper - WANFANG MED ONLINE

You Position: Home > Paper

Adjuvant chemotherapy and neo-adjuvant treatment of gastric cancer

( views:293, downloads:68 )

Author:: No author available

Journal Title:: CANCER RESEARCH AND CLINIC

Issue:: 10

DOI:: 10.3760/cma.j.issn.1006-9801.2008.10.001

Key Word:: 胃肿瘤;辅助化疗;新辅助化疗;Stomach neoplasms;Adjuvant chemotherapy;Neo-adjuvant chemotherapy

Abstract： Gastric cancer is common in the world. Only 40 % of the patients can be treated by radical operation. Even for those patients who undergo radical resection, the rate of recurrence or distant metastasis is high. To increase the chance of curative surgery and improve survival for gastric cancer, combined-modality treatments have been investigated. There are different therapeutic modes, chemotherapeutic regimens and treatment results between Eastern countries and Western countries. The current status and advance on the adjuvant and neo-adjuvant treatment of gastric cancer were reported.

Reference

[1]Jian-kun HU,Zhi-Xin Chen,Zong-Guang Zhou,etc.Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trials[J].2002,(6).
[2]方育,王亚军,李非,等.进展期胃癌新辅助化疗的临床研究[J].2007,(2).
[3]Barone C,Torri V,Cascinu S,etc.Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.[J].2007,99(8).
[4]Gebbia V,Romito S,De-Vita F,etc.Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study).[J].2007,18(8).
[5]Tres A,Nitti D,Van Cutsem E,etc.Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG.[J].2006,17(2).
[6]Donohue JH,Okawara GS,Ajani JA,etc.Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.[J].2006,24(24).
[7]Buzzoni R,Bordogna G,Di BM,etc.Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group.[J].2002,13(2).
[8]Cascinu S,Belfiglio M,Barni S,etc.Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente).[J].2000,11(7).
[9]de Vries JE,Cooperating Investigators of The Dutch Gastric Cancer Group,Tesselaar ME,etc.Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial.[J].2004,30(6).
[10]Ilaria, Panzini,Lorenzo, Gianni,Pier Paolo, Fattori,etc.Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses.[J].1900,88(1).
[11]Gallardo Rincon-D,Calderillo Ruiz-G,Onate Ocana-LF.Neoadjuvant chemotherapy with P-ELF (cisplatin, etoposide, leucovorin, 5-fluorouracil) followed by radical resection in patients with initially unresectable gastric adenocarcinoma: a phase II study.[J].2000,7(1).
[12]C G, Moertel,D S, Childs,J R, O'Fallon,etc.Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma.[J].1984,2(11).
[13]Gunderson LL,Smalley SR,Hundahl SA,etc.Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.[J].2001,345(10).
[14]Cunningham D,Allum WH,Stenning SP,etc.Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.[J].2006,355(1).
[15]Thompson A,Foo K,Zalcberg J,etc.Adjuvant and neoadjuvant therapy for gastric cancer using epirubicin/cisplatin/5-fluorouracil (ECF) and alternative regimens before and after chemoradiation.[J].2003,89(8).
[16]Pisters PW,Janjan N,Crane CH,etc.Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome.[J].2005,23(6).
[17]Kito T,Okabayashi K,Kitamura M,etc.Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomised trial. Gastric Cancer Surgical Study Group.[J].1999,354(9175).
[18]Bokemeyer C,Schroeder M,Clemens M,etc.A phase II study of paclitaxel, weekly, 24-hour continous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer.[J].2000,83(4).
[19]Kitamura M,Nashimoto A,Yamamoto S,etc.Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.[J].2003,21(12).
[20]Pisters PW,Janjan N,Lowy AM,etc.A pilot study of preoperative chemoradiotherapy for resectable gastric cancer.[J].2001,8(6).
[21]Wang Y,Chen SY,Sun YH,etc.An updated meta-analysis of adjuvant chemotherapy after curative resection for gastric cancer.[J].2008,34(11).
[22]Torri V,Strafiuso G,Bracci R,etc.Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.[J].2008,100(6).
[23]T, Nakajima.Adjuvant chemotherapy for gastric cancer in Japan: present status and suggestions for rational clinical trials.[J].1990,20(1).
[24]Kodaira S,Ohashi Y,Sakamoto J,etc.An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with curatively resected rectal cancer.[J].2007,96(8).
[25]C.C Earle,J.A Maroun.Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials[J].1999,35(7).
[26]T, Nakajima,K, Ota,S, Ishihara,etc.[Meta-analysis of 10 postoperative adjuvant chemotherapies for gastric cancer in CIH].[J].1994,21(11).
[27]Sakuramoto S,Sasako M,Yamaguchi T,etc.Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.[J].2007,357(18).
[28]Lynch PM,Mansfield PF,Feig B,etc.Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma.[J].2004,22(14).
[29]Schild SE,Henning GT,Donohue JH,etc.Results of irradiation or chemoirradiation following resection of gastric adenocarcinoma.[J].2000,46(3).
[30]Parkin DM,Pisani P,Ferlay J.Global cancer statistics.[J].1999,49(1).